Basic & Clinical Medicine ›› 2023, Vol. 43 ›› Issue (2): 317-321.doi: 10.16352/j.issn.1001-6325.2023.02.317

• Mini Reviews • Previous Articles     Next Articles

Research progress of exosome lncRNA in liquid biopsy of colorectal cancer

YAO Liuxu1,2, LI Yuhong3*, JIANG Zongming1*   

  1. 1. Department of Anesthesiology, Shaoxing People’s Hospital, Shaoxing 312000;
    2. School of Medicine, Shaoxing University Shaoxing 312000;
    3. Department of Anesthesiology, Shulan Hospital (Hangzhou), Shulan International Medical College, Zhejiang Shuren University, Hangzhou 310004, China
  • Received:2021-08-27 Revised:2022-04-07 Online:2023-02-05 Published:2023-02-02
  • Contact: *; jiangzhejiang120@163. com

Abstract: The diagnostic methods for colorectal cancer (CRC) are still improving. Liquid biopsy mainly analyzes the specific components of biological liquid. Long chain noncoding RNA (lncRNA) from exosomes can be analyzed by liquid biopsy technology.

Key words: colorectal cancer, liquid biopsy, exosome, lncRNA, biomarkers

CLC Number: